Tarsus Pharmaceuticals Inc (TARS) is set to release its DEC/2025 earnings performance on 02/23 16:05:00 ET in After Hours trading. Consensus forecasts predict a revenue of 144.96M and an earnings per share (EPS) of -0.19 for the DEC/2025. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings call highlights a solid financial performance with a 20% revenue increase and improved gross margins. Despite increased operating expenses, net income rose, indicating effective cost management. The company's profitability and cash flow growth are positive indicators. However, the absence of strategic or operational updates and acknowledgment of risks in forward-looking statements slightly tempers the outlook. Overall, the financial results are strong enough to predict a positive stock price movement over the next two weeks, especially given the 25% increase in cash flow and robust demand for the lead product.
The earnings call reveals strong financial health with high gross margins and a positive ROI on DTC campaigns. Despite some uncertainties in guidance specifics, the management's confidence in reaching a $2 billion sales target, ongoing international expansion, and a positive outlook for pipeline developments suggest optimism. The Q&A highlights potential growth despite seasonal disruptions, and no major expense increases beyond 2026. These factors, combined with strong market penetration and execution, indicate a positive sentiment, likely leading to a stock price increase of 2% to 8% over the next two weeks.
Tarsus Pharmaceuticals Inc (TARS) is scheduled to release its DEC/2025 earnings report on Feb 23, 2026, After Hours (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 144.96M in revenue and an EPS of -0.19 for Tarsus Pharmaceuticals Inc's DEC/2025.
Intellectia's exclusive AI algorithms forecast a {conclusion} for Tarsus Pharmaceuticals Inc's DEC/2025 earnings, with a prediction date of Feb 23, 2026. Tarsus Pharmaceuticals Inc {summary}
Leverage Intellectia's AI forecast to position trades ahead of the Feb 23, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!